Anxiolytic, hypnotic and sedative medication use in Australia
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Purpose: New sedative drugs have been marketed in Australia in the last few years. We examined the trends in the prescribing of subsidised anxiolytic, hypnotic and sedative (AHS) medication use in the Australian population from 2002 to 2007. Methods: We analysed the Medicare Australia and Drug Utilisation Sub‐Committee databases for AHS script data from 2002 to 2007 by source, class of prescriber, gender and 5‐year age groups. Scripts were converted to defined daily dose per 1000 population per day (DDD/1000 population/day) using Australian Bureau of Statistics population data. Results: Overall use of AHS increased from 23.76 to 24.11 DDD/1000 population/day between 2002 and 2007. Anxiolytic medication utilisation increased as hypnotic medication utilisation decreased. Diazepam was the most widely used anxiolytic followed by alprazolam and oxazepam. Temazepam was the most widely used hypnotic followed by nitrazepam. Medication use was concentrated in those aged ≥65 years with peak use in those aged 85–89 years. There was substantial use of anxiolytics in those aged 30–65 years. Age‐adjusted utilization was higher in females than males. Conclusions: The prescribing of AHS medications increased slightly over the last half decade. There is growing use of zolpidem on private prescription. The gender differences in use reflect the higher prevalence of anxiety and sleep disorders in women. The very high use of these drugs in elderly people warrants further exploration because of the concomitant increased risks of mortality and morbidity. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sleep Complaints Among Elderly Persons: An Epidemiologic Study of Three Communities
Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B., & Blazer, D. G. (1995) · Sleep · doi:10.1093/sleep/18.6.425 · Cited by 1,610
Comparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
Smith, M. T., Perlis, M. L., Park, A., Smith, M. S., Pennington, J., Giles, D. E., & Buysse, D. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.5 · Cited by 863 · cited 1×
“Behavioural therapy for insomnia has been shown to be as effective as pharmacotherapy.(9) In the UK, the”
MethodBenzodiazepines and Zolpidem for Chronic Insomnia: A Meta-analysis of Treatment Efficacy
Nowell, P. D. (1997) · JAMA · doi:10.1001/jama.1997.03550240060035 · Cited by 451
Benzodiazepines and Injurious Falls in Community Dwelling Elders
Pariente, A., Dartigues, J.-F., Benichou, J., Letenneur, L., Moore, N., & Fourrier-Réglat, A. (2008) · Drugs & Aging · doi:10.2165/00002512-200825010-00007 · Cited by 172 · cited 1×
“Despite this, the very high rates of sedative prescribing in the elderly is alarming given the higher risks of falls and accidents associated with benzodiazepines in this population.(25,27,37) Although dose tolerance and dose escalation of benzodiazepines is a community concern, this has not been borne out in recent e…”
BackgroundAzapirones for generalized anxiety disorder
Chessick, C. A., Allen, M. H., Thase, M. E., Batista Miralha da Cunha, A. A., Kapczinski, F., Silva de Lima, M., & dos Santos Souza, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006115 · Cited by 144 · cited 1×
“Buspirone has been shown to be an effective treatment for anxiety, but may not be superior to benzodiazepines in terms of efficacy or acceptability.(4) Rates of insomnia can be challenging to measure because of differences in insomnia case definitions, but they range from 10–40% in the adult population.”
Background
Cited by
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217
“This contrasts with the data presented here which suggests a dispensing ratio of antidepressants to anxiolytics/sedatives of almost 4:1, and with other recent Australian DDD-based data suggesting a ratio of above 3:1 (Hollingworth and Siskind, 2010; Hollingworth et al., 2010a).”
BackgroundResultInfluentialInacio, M. C., Lang, C., Bray, S. C. E., Visvanathan, R., Whitehead, C., Griffith, E. C., Evans, K., Corlis, M., & Wesselingh, S. (2021) · Internal Medicine Journal · doi:10.1111/imj.14871 · Cited by 91
Landolt, S., Rosemann, T., Blozik, E., Brüngger, B., & Huber, C. A. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s290104 · Cited by 34
“Benzodiazepines and Z-drugs are primarily prescribed for the treatment of insomnia, with benzodiazepines additionally being used for the treatment of anxiety.(2,3) Benzodiazepines and Z-drugs are some of the most frequently prescribed drugs in several health care systems, although their continued use is not supported…”
BackgroundMoylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822d0012 · Cited by 34
Metadata
- Authors
- Hollingworth, S. A., & Siskind, D. J.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2010-02-24
- Volume
- 19
- Issue
- 3
- Pages
- 280-288
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2012195951
- Cited by
- 92
- References
- 5
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anxiolytic, hypnotic and sedative medication use in Australia. https://app.cochat.ai/papers/10.1002/pds.1899
- The paper
- Hollingworth, S. A., & Siskind, D. J. (2010). Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.1899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.